E70.9
Disorder of aromatic amino-acid metabolism, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Disorders of aromatic amino-acid metabolism, categorized under ICD-10 code E70.9, refer to a group of rare inherited conditions that affect how the body processes certain amino acids. Aromatic amino acids include phenylalanine, tyrosine, and tryptophan, which are vital building blocks for proteins and serve as precursors for important neurotransmitters and hormones. When these metabolic pathways are disrupted, it can lead to a variety of health issues. Although the exact causes of these disorders can vary, they often involve genetic mutations that impair specific enzymes involved in amino acid breakdown. Due to their rarity and complexity, these conditions are typically diagnosed and managed in specialized medical settings.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes responsible for metabolizing aromatic amino acids Inheritance patterns, often autosomal recessive, meaning both parents must pass on the mutated gene Potential environmental factors that might trigger or exacerbate symptoms in some cases
Key Symptoms: Developmental delays and intellectual disabilities in children Behavioral issues, including irritability and mood swings Signs of metabolic crises, such as vomiting, lethargy, or decreased feeding in infants Unusual body odors, sometimes described as musty or mousy Skin rashes or hair depigmentation in some cases Possible neurological symptoms like seizures or muscle weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosing disorders of aromatic amino-acid metabolism involves a combination of clinical evaluation and laboratory testing. Newborn screening programs often include tests that detect abnormal levels of amino acids in the blood. Confirmatory tests may involve measuring amino acid concentrations through chromatography and assessing enzyme activities. Genetic testing can identify specific mutations responsible for the disorder, helping to establish a definitive diagnosis. Early detection is crucial to prevent or minimize neurological and developmental complications.
Treatment Protocols: Management of these metabolic disorders typically includes dietary modifications to control intake of affected amino acids, especially phenylalanine and tyrosine, to prevent toxic accumulation. Special formulas and medical foods are used to ensure adequate nutrition while minimizing substrate overload. Additionally, some patients may benefit from pharmacological treatments such as enzyme replacement therapy or cofactor supplementation. Regular monitoring of amino acid levels and neurological assessments are essential components of ongoing care. Supportive therapies, including physical, occupational, and speech therapy, can assist in addressing developmental challenges.
Clinical Advice & FAQs
Billing Guidance
Is E70.9 a billable ICD-10 code?
Yes, E70.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.9?
Clinical documentation must specify the nature of Disorder of aromatic amino-acid metabolism, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference